Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Dirks

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Psychiatry|September 27, 2019
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)Maurizio Fava, Bryan Dirks, Marlene P Freeman, et al.
Journal of Child and Adolescent Psychopharmacology|December 29, 2010
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label studyAtilla Turgay, Lawrence Ginsberg, Elias Sarkis, et al.
Depression and Anxiety|April 18, 2020
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysisMarlene P Freeman, Maurizio Fava, Bryan Dirks, et al.
Journal of Affective Disorders|September 2, 2020
Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY studyRichard C Shelton, Maurizio Fava, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|December 2, 2020
Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder: Secondary Analysis From CLARITYManish K Jha, Maurizio Fava, Marlene P Freeman, et al.
International Clinical Psychopharmacology|August 18, 2020
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity studyGeorge I Papakostas, Maurizio Fava, Marlene P Freeman, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Psychiatry|September 27, 2019
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)Maurizio Fava, Bryan Dirks, Marlene P Freeman, et al.
Journal of Child and Adolescent Psychopharmacology|December 29, 2010
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label studyAtilla Turgay, Lawrence Ginsberg, Elias Sarkis, et al.
Depression and Anxiety|April 18, 2020
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysisMarlene P Freeman, Maurizio Fava, Bryan Dirks, et al.
Journal of Affective Disorders|September 2, 2020
Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY studyRichard C Shelton, Maurizio Fava, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|December 2, 2020
Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder: Secondary Analysis From CLARITYManish K Jha, Maurizio Fava, Marlene P Freeman, et al.
International Clinical Psychopharmacology|August 18, 2020
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity studyGeorge I Papakostas, Maurizio Fava, Marlene P Freeman, et al.
Pageof 4